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INTRODUCTION

Measures
 Awareness. T2D patients were dichotomized by their level of awareness of their HbA1c level (i.e., reported an HbA1c value versus those who reported a "don't know" response) for each year.
 Demographics and Patient Characteristics. Age, gender, race/ethnicity, household income, education, diabetes treatment, and diabetes complications were all assessed for diabetes respondents.
 Health Outcomes. The Mental Component Summary (MCS) and Physical Component Summary (PCS) scores from the Short Form-36 version 2 (SF-36v2) were included as measures of health status. Absenteeism, presenteeism, overall work impairment, and activity impairment metrics from the Work Productivity and Activity Impairment-General Health scale (WPAI-GH) were used as measures of indirect costs. The number of healthcare resource use events in the past six months was also reported.
Statistical Analysis
 Levels of awareness were reported descriptively for each year of the NHWS.
 Comparisons were made between those who were aware of their HbA1c versus those who were unaware with respect to demographics and patient characteristics for each year of the NHWS with chi-square tests and one-way ANOVAS.
 Regression models (i.e., generalized linear models) were used to compare those who were aware and unaware with respect to health status, WPAI-GH metrics, and healthcare resource, controlling for demographics and health characteristics. NHWS 2013 results were used for the regression models.  Those who are unaware are less likely to be treated and also had fewer physicians than patients who are aware, yet more hospitalizations, suggesting their disease is not being properly managed.
METHODS
 Improved patient awareness of HbA1c level may have societal benefits in terms of reduced costs as well as improved health outcomes for patients.
CONCLUSIONS OBJECTIVE:
Maintaining glycemic control for patients with type 2 diabetes (T2D) is associated with a reduced risk of future complications. Proper patient awareness of glycated hemoglobin level (HbA1c) is important to facilitate adherence and improve outcomes. This study profiles how HbA1c awareness has changed over time and the consequences of poor awareness.
METHODS:
Data from the US National Health and Wellness Survey (NHWS) from 2006 (n=62,834) through 2013 (n=75,000) were used in the analysis. The NHWS is an annual, patient-reported, crosssectional survey fielded to match the demographic characteristics of the US adult population. Patient awareness of their HbA1c level (i.e., a reported value versus a "don't know" response) was examined each year. Differences between those who were aware versus unaware were made with respect to health status (using the SF-36v2), work productivity loss (using the WPAI-GH), and healthcare resource in a series of regression models controlling for demographics and health characteristics.
RESULTS:
Awareness of HbA1c level improved from 26.6% (in 2006) to 56.4% (in 2013). In 2013, patients who are aware (n=4,658) were more likely to be older (60.5 versus 57.2 years), non-Hispanic white (71.4% versus 61.1%), treating with oral/insulin/non-insulin injectable (87.8% versus 76.1%), and more likely to have had diabetic complications compared with those who were unaware (n=3,040; all p<.05). Holding demographics and health history constant, lack of awareness was associated with poorer health utilities (0.70 versus 0.68), more overall work impairment (17.9% versus 20.8%), and more hospitalizations in the past six months (0.26 versus 0.22), among other outcomes (all p<.05).
CONCLUSION:
Awareness of HbA1c has increased over time, though appears disproportionately higher among patients of high socioeconomic status and higher risk (i.e., those with complications and using insulin). Awareness was also independently associated with poorer health outcomes suggesting improved patient education may have significant societal benefits.
ABSTRACT  In 2013, patients who were aware (12.7 M; n=4,658) were more likely to be older (60.5 versus 57.2 years), non-Hispanic white (71.4% versus 61.1%), treating with oral/insulin/noninsulin injectable (87.8% versus 76.1%), and more likely to have had diabetic complications compared with those who were unaware (9.3 M; n=3,040; all p<.05) ( Table 1) .
 Additionally, patients who were aware were more likely to be college educated and have higher household incomes (all p<.05) compared with those who were unaware ( Table 1) .
 These demographic, treatment, and complication patterns have remained fairly consistent when comparing aware versus unaware patients from 2006 through 2013 (results from 2007-2012 not shown).
-Interestingly, the proportion of patients aware of their HbA1c level who are Hispanic has increased from 2006 (8.5%) to 2013 (11.3%) ( Table 1) .
 Holding demographics and health history constant, lack of awareness was associated with poorer mental health (Adjusted means=48.30 versus 49.66, p<.05) and health utilities (Adjusted means= 0.70 versus 0.68, p<.05).
 From an economic perspective, lack of awareness was associated with higher indirect costs (Figure 2 ) along with more hospitalizations in the past six months (Adjusted means=0.26 versus 0.22, p<.05).  Interestingly, lack of awareness was associated with few physician visits (Adjusted means=5.15 versus 6.24, p<.05), which may be related to the underlying reasons for their lack of awareness (e.g., low health literacy).
Figure 1: Awareness of HbA1c Level Among Patients With T2D
